According to new data from the Centers for Disease Control and Prevention's (CDC's) 2013 National Immunization Survey Teen, the number of girls and boys ages 13-17 years receiving human papillomavirus (HPV) vaccine remains unacceptably low, despite a slight increase in vaccination coverage since 2012.
Availability of emergency contraception (EC) has broadened since the FDA ruled that generic EC could be sold on store shelves and would no longer require proof of age.
Data presented at the AIDS 2014 international conference indicates that oral HIV pre-exposure prophylaxis (PrEP) provides a high degree of protection against HIV infection, even for individuals who miss some daily doses.
Science is looking at a wireless microchip implant, with remote drug delivery control, that is designed to last up to 16 years.
